Market Overview

UPDATE: Credit Suisse Raises PT on Medidata Solutions Following 1Q13 Results

Related MDSO
Medidata Up 3% After Positive Comments From Stephen Weiss
UPDATE: Stifel Initiates Coverage On Medidata Solutions On Leading Software Platform

In a report published Tuesday, Credit Suisse analyst Glen Santangelo reiterated an Outperform rating on Medidata Solutions (NASDAQ: MDSO), and raised the price target from $75.00 to $80.00.

In the report, Credit Suisse noted, “On the back of MDSO's 1Q13 results, continued benefit from competitive market share gains and further evidence of the company's ability to grow its wallet share within its new and existing customer base. In this report we attempt to provide a different valuation framework for the company given our understanding of the preferred valuation metrics for the Healthcare Services investor vs. the valuation metrics most relevant to ‘cloud companies.'”

Medidata Solutions closed on Monday at $69.87.

Posted-In: Credit Suisse Glen SantangeloAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (MDSO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free